V Schaerer
An intensive care unit outbreak with multi-drug-resistant Pseudomonas aeruginosa - spotlight on sinks.
Schaerer V, Meier M, Schuepbach R, Zinkernagel A, Boumasmoud M, Chakrakodi B, Brugger S, Fröhlich M, Wolfensberger A, Sax H, Kuster S, Schreiber P. An intensive care unit outbreak with multi-drug-resistant Pseudomonas aeruginosa - spotlight on sinks. J Hosp Infect 2023; 139:161-167.
19.06.2023An intensive care unit outbreak with multi-drug-resistant Pseudomonas aeruginosa - spotlight on sinks.
19.06.2023J Hosp Infect 2023; 139:161-167
Schaerer V, Meier M-T, Schuepbach Reto Andreas, Zinkernagel Annelies S, Boumasmoud M, Chakrakodi B, Brugger Silvio D, Fröhlich M, Wolfensberger Aline, Sax Hugo, Kuster Stefan, Schreiber Peter W
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
Schaerer V, Rauch A, Fehr J, Metzner K, Furrer H, Günthard H, Böni J, Aouri M, Decosterd L, Schmid P, Stoeckle M, Cavassini M, Ambrosioni J, Ledergerber B, Kovari H, Haubitz S, Swiss HIV Cohort Study. Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Med 2015; 16:599-607.
02.07.2015Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
02.07.2015HIV Med 2015; 16:599-607
Schaerer V, Rauch A, Fehr J, Metzner K J, Furrer H, Günthard H F, Böni J, Aouri M, Decosterd L, Schmid Patrick, Stoeckle M, Cavassini M, Ambrosioni J, Ledergerber B, Kovari H, Haubitz S, Swiss HIV Cohort Study